PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19013351-0 2008 Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae. Tigecycline 62-73 CTX-M-15 Klebsiella pneumoniae 103-135 19013351-7 2008 Limited agreement (<80%) was found between the broth microdilution and the Etest methods when determining the in-vitro activity of tigecycline against ESBL- producing K. pneumoniae and K. oxytoca. Tigecycline 134-145 CTX-M-15 Klebsiella pneumoniae 154-158 18787741-0 2008 In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Tigecycline 21-32 CTX-M-15 Klebsiella pneumoniae 62-94 18787741-2 2008 In this study, we evaluated the in vitro antimicrobial activity of tigecycline against ESBL-producing Enterobacteriaceae, including Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Tigecycline 67-78 CTX-M-15 Klebsiella pneumoniae 87-91 18787741-4 2008 The in vitro activity of tigecycline against these ESBL producers was tested by use of Etest strips. Tigecycline 25-36 CTX-M-15 Klebsiella pneumoniae 51-55 18787741-6 2008 CONCLUSIONS: Tigecycline, a new semisynthetic glycylcycline, may be considered an alternative drug of choice for patients infected with ESBL-producing bacteria. Tigecycline 13-24 CTX-M-15 Klebsiella pneumoniae 136-140 30068997-5 2018 This study identified 67 eravacycline-nonsusceptible isolates; among the extended-spectrum beta-lactamase (ESBL)-positive isolates, eravacycline-nonsusceptible isolates were detected more frequently than tigecycline-nonsusceptible isolates (21.7% vs. 9.4%, p = 0.001). Tigecycline 204-215 CTX-M-15 Klebsiella pneumoniae 73-105 16870760-12 2006 Tigecycline, lacking cross-resistance with other compounds, could represent an opportunity to reduce the intensity of selection for ESBL-producing organisms derived from the use of other antimicrobial agents. Tigecycline 0-11 CTX-M-15 Klebsiella pneumoniae 132-136